electroCore Receives FDA Emergency Use Authorization for use of gammaCore Sapphire CV For COVID-19 Treatment

FDA Emergency Use Authorization gammaCore Sapphire COVID19
Image: gammaCore
One of the symptoms of COVID-19 is respiratory problems, and people with asthma are badly affected by the disease as it can make breathing even more difficult. Now, electroCore, a commercial-stage bioelectronic medicine company, announced that the FDA has issued an Emergency Use Authorization (EUA) authorizing the use of gammaCore Sapphire™ CV non-invasive vagus nerve […]